GBL industrial cleaning chemical manufacturer

When it has been copared to other normally industrial used or daily life used cleaner, the PURE GBL cleaner could be clearly distinguished by its high concentration. GBL cleaner is to be diluted with water to a desired concentration, PURE GBL Cleaner can be diluted with water up to a maximum ratio of 1:5. It is therefore necessary to handle GBL cleaner with care and follow safety instructions.

When people use the related GBL products such as the PURE GBL , they should wear waterproof safety gloves and safety goggles as the most minimum protection. When people need to use the GBL cleaner with very high concentration, it is also very advisable to wear protective clothing and never spray towards people or animals. Before the using of the GBL cleaner, people should firstly read the package leaflet. Should always be stored out of reach to people, children, and animals.

Gamma-butyrolactone is an organic compound, more specifically a lactone, with the gross formula C4H6O2. The substance occurs as a colourless, oily liquid, which is low in hygroscopicity. It is a solvent and reagent in chemical reactions.

Gamma butyrolactone is a chemical. People use it as medicine but this article is about the cleaning product known as GBL. Be careful not to confuse gamma butyrolactone (GBL) with gamma hydroxybutyrate (GHB).

Despite serious safety concerns and illegality, people take gamma butyrolactone for improving athletic performance, sleep, and sexual performance and pleasure. They also take it for relieving depression and stress, prolonging life, promoting clear thinking, causing relaxation, and releasing growth hormone. GBL is also used to trim fat and as a body- or muscle-builder. Some people take it as a recreational drug.

How does it work?

Gamma butyrolactone is converted in the body to gamma hydroxybutyrate (GHB) which affects several nerve pathways in the brain. So please be extra careful when using this cleaning product.

For a trusted online supplier please check : Buy GBL Online with GBLlab.com

Usualy liqud is used as multi purpouse gbl cleaner. Saying more accurate gbl cleaner can be used as described below.

Glue remover. Gbl can perfectly cllean glue from stickers, foils, etc.
Ink remover. Gbl widly used for needs in serving printers, cleaning cartridges.
Resin remover. GBL cleaner from our shop can be applyed for cleaning car body from road resin and etc.
Wood stripper. Gbl can esylly strip wood from different kinds of pollish and wood paints.
Alloy wheels cleaner. Gamma bytirolactone perfectly removes stains from light alloy wheels surface.
Removal of graffiti. Best practice of household use of GBL is removing graffity from walls.
Oil removing. Motor oil, silicone oil, cooking oil and many other variants of oil stains can be washed away with help of GBL.

We deliver on the german market to, please check : gbl bestellen

Euroreta, UAB (www.gbllab.com) is engaged in the business of manufacturing, packaging and repackaging of chemicals and providing packaged chemicals and metals to its customers.

Contact Us:
UAB Euroreta
Reg. No. 304600045
Reg. address: Vienuolio g. 4, Vilnius,
LT-01104
Call: +370 67 88 98 58
Email: info@gbllab.com

PT. Kamadjaja Logistics

PT. Kamadjaja Logistics was recently named Frost & Sullivan’s 2017 Indonesia Domestic Warehouse Services Provider of the Year at the annual Frost & Sullivan Indonesia Excellence Awards ceremony, held at the Mandarin Oriental Hotel, Jakarta on 28 November 2017.

“Recognizing the importance of innovation and meeting customer needs, PT. Kamadjaja Logistics has focused on developing and improving its warehousing infrastructure and technologies. The company’s cutting edge warehousing facilities such as its successful KLOG PARK establishments have enabled customers to derive maximum value from top-notch services, allowing the company to enjoy a better relationship with customers,” said Norazah Bachok, Research Analyst for Transportation & Logistics at Frost & Sullivan.

She continued, “PT. Kamadjaja Logistics also aims for more partnerships with various regional participants to boost opportunities. An extensive product portfolio, new business chain ventures, regional partnerships, and expansion strategies allow the company to enhance its brand recognition and value in the industry.”

“We are delighted to receive the 2017 Indonesia Domestic Warehouse Services Provider of the Year award from Frost & Sullivan. This recognition is a huge encouragement to the team as we strive to provide value to our customers by delivering innovative and excellent logistics services,” said Ivy Kamadjaja, Deputy CEO of PT. Kamadjaja Logistics.

The recipients of the annual Frost & Sullivan Indonesia Excellence Awards were identified based on in-depth research conducted by Frost & Sullivan’s analysts. The award categories offered each year are carefully reviewed and evaluated to reflect the current market landscape and include new emerging trends.

The short-listed companies were then evaluated on a variety of actual market performance indicators which include revenue growth; market share and growth in market share; leadership in product innovation; marketing strategy and business development strategy.

About PT. Kamadjaja Logistics

PT. Kamadjaja Logistics is widely recognized as a pioneer in the logistics industry in Indonesia. Established five decades ago it is now the largest Indonesian company that provides integrated and modern logistics solutions. Equipped with 29 Distribution Centers spread over 16 major cities in Indonesia and covering over 355 destinations, PT. Kamadjaja Logistics has the largest nationwide logistics network in the country.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion

Contact:
Fuad Misbah
Corporate Communications – Indonesia
Email: fuad.misbah@frost.com
http://www.frost.com

The Mary C. O’Keefe Cultural Center Will Host Hurricane Harvey Benefit Show September 24th

Who knew a devastating hurricane in the Texas Gulf Coast would inspire so many communities across America to pitch-in and help? But that’s exactly what’s happening September 24th in Ocean Springs, Mississippi when “FRANK & LIZA” come to the Mary C. This strong community already knows the impact of a record-breaking storm. In 2005, Hurricane Katrina ravaged their own coastline. But today, it’s Houston and the Texas coast that urgently need the help.

Thanks to the Mary C. O’Keefe Cultural Center, the exhilarating musical tribute to “Frank Sinatra & Liza Minnelli” will come to Ocean Springs for one Sunday matinee benefiting the Hurricane Harvey Relief Fund. The show is a rapid-paced musical journey through the classic and timeless hits of Frank Sinatra and the Broadway-like song and dance spectacle that is Liza Minnelli’s trademark.

Described as “warm, witty and sexy”, the Las Vegas show features a delightful exchange of music, humor and dazzling duets between two of the most talented artists working today – Dave Halston and Suzanne Goulet. Together, “FRANK & LIZA” will not only thrill a willing audience, they will make it easy for virtually anyone to assist in the Hurricane Harvey relief effort.

Seating is limited. Tickets are available online now for $25.

About the Hurricane Harvey Relief Fund:
After receiving an overwhelming number of inquiries from citizens and companies who want to help, Houston Mayor Sylvester Turner and County Judge Ed Emmett have established the Hurricane Harvey Relief Fund that will accept tax deductible flood relief donations for victims that have been affected by the recent floods. The fund will be housed at the Greater Houston Community Foundation, a 501(c)(3) public charity.

About the Artists:

Dave Halston comes with an impressive resume – working a multitude of theatres, casinos, special events and private parties coast to coast – and in most cases, leaving the audience stunned. As one observer described it, “Dave Halston somehow casts a spell, and they always want more.” Even Barbara Sinatra was brought to tears when Dave performed for her at an exclusive private event. She called his performance “wonderful” and noted specifically the fine job Dave did with Sinatra’s signature song “My Way”.

In addition to Mrs. Sinatra, Dave has also entertained Jeanne Martin (Mrs. Dean Martin), recording artists Michael Feinstein, Steve Tyrell and Mr. Las Vegas himself, Wayne Newton, among other notables.

Suzanne Goulet was born in Montreal, Canada and has been dancing since the age of 3. She starred in “Fantastique” at the Sheraton Bal Harbour in Miami Beach, then at the Sands Casino in Atlantic City and at the Condado Plaza in San Juan, Puerto Rico. She then joined “Hooray for Hollywood” for an international tour to Spain, Switzerland and Japan. She also choreographed and danced for a show on the “Song of America” cruise ship from RCCL. After studying voice in New York City, she won the “Smirnoff Makes You A Star” competition and began her career as a tribute artist.

In 1996, Suzanne joined “Legends in Concert” at Bally’s Grand in Atlantic City. Then she followed the show to the Imperial Palace in Las Vegas where she received rave reviews and numerous awards.

Show Details:

“FRANK & LIZA”
A Musical Tribute to Frank Sinatra and Liza Minnelli
2:30PM | Sunday, September 24th, 2017
TICKETS: $25

The Mary C. O’Keefe Cultural Center of Arts and Education
1600 Government Street
Ocean Springs, Mississippi 39564
228.818.2878

Hong Kong Medical Block Chain MCHK” great success at the “20th China International Investment and Trade Fair”

“Hong Kong Medical Block Chain MCHK” glory set sail

“Hong Kong Medical Block Chain MCHK” participated in the “20th China International Investment and Trade Fair”

1.On September 9, 2018, at the twentieth session of the China International Fair for Investment and Trade, more than 1,000 industrial and commercial groups, about 5,000 companies and more than 120,000 merchants from more than 110 countries and regions gathered in Xiamen .Medisun Medical Group participated in the forum.

The Medisun market team gathered at the Hong Kong medical block chain MCHK at the center booth of Xiajiahui

Terry Lierman (left), Chairman of Medisun Medical Group, and Mr. Danny Wong (right), Executive Chairman, at the “Hong Kong Medical Block Chain” booth

“Hong Kong Medical Block Chain MCHK” hosted the “Blockchain 3.0 Energizing Entity Economic Forum”
Organized by the China Investment Association, Tsinghua x-lab Ivy League Research Institute and Medisun Medical Group’s “Block Chain 3.0 Energizing Entity Economic Forum” became a highlight of the current Xiamen Fair.
Blockchain 3.0 empowers the real economy and has become a new consensus in China’s blockchain industry. Blockchain 3.0 represents the Internet of Things-based blockchain 3.0 technology that truly links the digital economy to the real economy to form a complete blockchain technology, business and financial services ecosystem for the service industry.


Terry Lierman, Chairman of Medisun Medical Group, addressed the investment forum

Mr. Danny Wong (first from right), Chairman of the Medisun Medical Group, signed the strategic cooperation of the “Ticket Reform Laboratory”

Terry Lierman, Chairman of Medisun Medical Group, introduced the Hong Kong medical block chain MCHK

Terry Lierman, Chairman of the American Medical Group, said that the most critical factors in the health care system are Transparecny, Quality and Access. The reason why the US medical system does not have such an accident in China is because the US FDA adheres to the standard approval and monitoring process for medical products. This is the effectiveness of the medical system. The Hong Kong medical blockchain will also be reliable. The medical platform is based on blockchain technology. Any vaccine products and medical products are produced, circulated and used on the MCHK platform are transparent and traceable.

“Hong Kong Medical Chain Chain MCHK”, as the Hong Kong medical service public chain, is based on the collection of 500 advanced medical institutions in Hong Kong. It integrates 5,000 medical institutions in the Greater Bay Area within three years, and uses the blockchain technology as a framework to integrate Medisun Medical The Group’s rich clinical research and development technology and experience in regenerative Medisun have enhanced the trust and consensus of the children’s vaccine and cancer vaccine industry, promoted the integration and upgrading of the medical industry in Dawan District, and achieved the first to meet the international standard level in the “9+2 City” medical service system in Dawan District.

“Hong Kong Medical Block Chain MCHK” won the “Blockchain Innovation Enterprise Award”

This forum held the awarding ceremony of “Blockchain 3.0 Encouraging Entity Economy Top Ten Innovative Enterprises”. “Hong Kong Medical Block Chain MCHK” won the award as the latest medical health platform based on blockchain technology.

Mr. Danny Wong (third from left), Executive Chairman of Medisun Medical Group, received the award.

Launching Ceremony of “Hong Kong Medical Blockchain MCHK”

On September 10th, the launching ceremony of the Hong Kong medical block chain MCHK was held in Xiamen. The chairman of the group, Terry Lierman, and the executive chairman of the group, Mr. Danny Wong, co-chaired and opened the champagne. The marketing team raised a toast to celebrate this memorable day!

Hong Kong Medical Block Chain MCHK Launch Ceremony

MCHK “Hong Kong Medical Block Chain” Hong Kong Medical Services Public Link is a joint venture of Medisun Medical Group.

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative product technology, as well as quality hospitals and treatment centers. Medisun has long-term cooperation with the Johns Hopkins Life Science Center and the Harvard University Stem Cell Institute, working on the investment and research and development of new technologies in the field of regenerative worldwide, and conducting clinical trials in many well-known hospitals in mainland China and Hong Kong; In cooperation with Tsinghua University, Medisun established the “Medical Institute of Cell Technology of Tsinghua University” and “Medical University Tsinghua University Regenerative Medisun Industry Fund”.

The Medisun Regenerative Centre is located in Kowloon Bay, Hong Kong. It has an international GMP standard medical laboratory, cancer treatment center and anti-aging center. It provides immune cell therapy, a variety of stem cell health treatments, a number of child and adult vaccinations and a full range of biomedical products. Testing to provide customers with the most predictable health protection.

For more information, please visit http://www.medisun.hk/

Hong Kong Medical Block Chain MCHK participated in the “20th China International Investment and Trade Fair”

“Hong Kong Medical Block Chain MCHK” glory set sail

“Hong Kong Medical Block Chain MCHK” participated in the “20th China International Investment and Trade Fair”

1.On September 9, 2018, at the twentieth session of the China International Fair for Investment and Trade, more than 1,000 industrial and commercial groups, about 5,000 companies and more than 120,000 merchants from more than 110 countries and regions gathered in Xiamen .Medisun Medical Group participated in the forum.

The Medisun market team gathered at the Hong Kong medical block chain MCHK at the center booth of Xiajiahui

Terry Lierman (left), Chairman of Medisun Medical Group, and Mr. Danny Wong (right), Executive Chairman, at the “Hong Kong Medical Block Chain” booth

“Hong Kong Medical Block Chain MCHK” hosted the “Blockchain 3.0 Energizing Entity Economic Forum”
Organized by the China Investment Association, Tsinghua x-lab Ivy League Research Institute and Medisun Medical Group’s “Block Chain 3.0 Energizing Entity Economic Forum” became a highlight of the current Xiamen Fair.
Blockchain 3.0 empowers the real economy and has become a new consensus in China’s blockchain industry. Blockchain 3.0 represents the Internet of Things-based blockchain 3.0 technology that truly links the digital economy to the real economy to form a complete blockchain technology, business and financial services ecosystem for the service industry.


Terry Lierman, Chairman of Medisun Medical Group, addressed the investment forum

Mr. Danny Wong (first from right), Chairman of the Medisun Medical Group, signed the strategic cooperation of the “Ticket Reform Laboratory”

Terry Lierman, Chairman of Medisun Medical Group, introduced the Hong Kong medical block chain MCHK

Terry Lierman, Chairman of the American Medical Group, said that the most critical factors in the health care system are Transparecny, Quality and Access. The reason why the US medical system does not have such an accident in China is because the US FDA adheres to the standard approval and monitoring process for medical products. This is the effectiveness of the medical system. The Hong Kong medical blockchain will also be reliable. The medical platform is based on blockchain technology. Any vaccine products and medical products are produced, circulated and used on the MCHK platform are transparent and traceable.

“Hong Kong Medical Chain Chain MCHK”, as the Hong Kong medical service public chain, is based on the collection of 500 advanced medical institutions in Hong Kong. It integrates 5,000 medical institutions in the Greater Bay Area within three years, and uses the blockchain technology as a framework to integrate Medisun Medical The Group’s rich clinical research and development technology and experience in regenerative Medisun have enhanced the trust and consensus of the children’s vaccine and cancer vaccine industry, promoted the integration and upgrading of the medical industry in Dawan District, and achieved the first to meet the international standard level in the “9+2 City” medical service system in Dawan District.

“Hong Kong Medical Block Chain MCHK” won the “Blockchain Innovation Enterprise Award”

This forum held the awarding ceremony of “Blockchain 3.0 Encouraging Entity Economy Top Ten Innovative Enterprises”. “Hong Kong Medical Block Chain MCHK” won the award as the latest medical health platform based on blockchain technology.

Mr. Danny Wong (third from left), Executive Chairman of Medisun Medical Group, received the award.

Launching Ceremony of “Hong Kong Medical Blockchain MCHK”

On September 10th, the launching ceremony of the Hong Kong medical block chain MCHK was held in Xiamen. The chairman of the group, Terry Lierman, and the executive chairman of the group, Mr. Danny Wong, co-chaired and opened the champagne. The marketing team raised a toast to celebrate this memorable day!

Hong Kong Medical Block Chain MCHK Launch Ceremony

MCHK “Hong Kong Medical Block Chain” Hong Kong Medical Services Public Link is a joint venture of Medisun Medical Group.

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative product technology, as well as quality hospitals and treatment centers. Medisun has long-term cooperation with the Johns Hopkins Life Science Center and the Harvard University Stem Cell Institute, working on the investment and research and development of new technologies in the field of regenerative worldwide, and conducting clinical trials in many well-known hospitals in mainland China and Hong Kong; In cooperation with Tsinghua University, Medisun established the “Medical Institute of Cell Technology of Tsinghua University” and “Medical University Tsinghua University Regenerative Medisun Industry Fund”.

The Medisun Regenerative Centre is located in Kowloon Bay, Hong Kong. It has an international GMP standard medical laboratory, cancer treatment center and anti-aging center. It provides immune cell therapy, a variety of stem cell health treatments, a number of child and adult vaccinations and a full range of biomedical products. Testing to provide customers with the most predictable health protection.

For more information, please visit http://www.medisun.hk/

Best Scientific Education Instruments from ArrEssPro Scientific

ArrEssPro offers a complete range of lab equipment, cleanroom … Shop our range of lab equipment and scientific instruments including fume hoods and more.

Below you’ll find some of our featured products from our wide selection of manufacturers. You’ll also see a couple featured categories. As well as be able to check on the latest News happening here at ArrEssPro, and the latest Blog articles.

ArrEssPro LLC is a Texas based company specializing in online sales. We offer all kind of scientific equipment and supplies. Here are few of our latest products:

Benchmark Scientific Shaking Water Bath

The seamless, stainless steel chamber has a 12 liter capacity and includes an universal spring-loaded platform for securing 15 & 50ml test tubes, as well as Erlenmeyer flasks and media bottles up to 1 liter. A hinged and removable lid is also included to reduce energy waste, prevent splashing and divert condensation away from samples.

Easy to use controls allow the user to digitally select and monitor time, temperature and shaking speed, while a constant monitoring system ensures accuracy over each parameter.

Optional test tube racks are available for microtubes and custom-designed racks can also be made available by request.

Orbital shaking motion
Included spring platform accepts tubes, bottles and flasks
Digital control of time, temperature and speed
Compact design, conserves bench space

Specifications:
Temp. Range: Ambient +5 to 80C
Speed Range: 30 to 200 rpm
Orbit: 25mm / 1 in.
Temp. Accuracy:+/- 0.3C (at 37C)
Temp. Increments: 0.1C
Temp. Uniformity:+/- 0.2C (at 37C)
Capacity: 12L
Dimensions:(w x d x h) 12.2 x 13.5 x 12 in.31 x 34.5 x 30 cm )
Chamber: Stainless Steel
Chamber Dimensions: 5.3 x 9.4 x 5.5 in. / 13.5 x 24 x 14 cm
Timer: 1 min. to 48 hours, or continuous
Weight: 31 lbs / 14 kg)
Electrical:115V, 50-60Hz, 400W
Warranty:2 Years

https://arresspro.com/quincy-lab-286-cu-ft-air-forced-lab-oven

Model 40AF Forced Air Convection Oven is designed to meet the laboratory needs of industry, research organizations and schools. It is well-crafted and versatile and can be used for drying, baking, sterilizing. evaporating, heat treating, annealing and testing.

Advanced Design
Cabinets are as attractive as they are durable. Exteriors are painted light gray and have a hard, scratch-resistant hammer finish. Doors open with high impact thermoplastic handles. Cabinets have heavy steel double-wall construction. Work space is insulated from the outer cabinet with one inch of high density mineral wool, and interiors are made of corrosive-resistant aluminized steel.

Controls
Quincy Lab uses quality UL and CSA recognized components in all ovens. The control panel is equipped with an illuminated ON-OFF rocker switch and a heat/cycle pilot light. Temperature is controlled by an automatic Hydraulic or a bi-metal thermostat.

Heating Elements
Energy efficient, low-watt density incoloy sheathed elements are engineered into a compact design for quick run-up and recovery times. Temperature uniformity is greatly improved by a perforated heat shield which absorbs radiant heat and distributes it more evenly. Models have temperature range to 225C (437F).

Major Science Digital Peristaltic Pump

The easy-to-use pump design allows for several different silicon tubing sizes to be fitted. This gives the user a wider variety of flow rates.

The MU-D series is also reversible providing better convenience and flexibility to the user. The digital control provides high accurate rpm performance.

MU-D01 pump is a digital controlled mode with a solid 50W brushless motor, and MU-D02 is designed with a higher horsepower, 100W for higher volume demands required.

MU-D03 pump is the most powerful pump in this series which packs with powerful pump head, allows the flow rate to up to 3.3 litre/min with thicker tubing (1.6mm).

Select the appropriate model for your lab with economical yet powerful enough peristaltic pump.

Features:

For MU-D01 and MU-D02:

Digital microprocessor control for accurate control
Compact size for easy transportation
High quality Watson Marlow Easy load pump head
Flow rate range from 1.2 to 1140 ml/min for MU-D01 and 0.3 to 2280 ml/min for MU-D02 for wide applications
Reversible for purging

For MU-D03:

Digital microprocessor control for accurate control
High quality Watson Marlow pump head
Speed range from 20 to 300 rpm with 1 rpm increment
Flow rates from 0.8 ml/min to 3.3 litre/min using 1.6 mm wall thickness tubing
Robust pumphead construction with PPS (polyphenylene sulphide) track and rotor and stainless steel rollers and bearings
High efficiency maintenance free brushless DC motor
Tubing size ranges from 0.5mm to 8.0 mm (I.D) for wider application and usage

Please visit our online store and contact us for any questions:
https://arresspro.com/
ArrEssPro LLC
PO Box 51663
Denton, TX 76206-1663

Hong Kong Regenerative Medisun Association launched by Medisun

Medisun launched the “Hong Kong Regenerative Medisun Association”

On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.

Hong Kong Regenerative Medisun Association goals

The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:

1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;

2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;

3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;

4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;

5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.

Member of the First Council of the Hong Kong Regenerative Medisun Association

Position

Name

 Qualifications

Chairman

Danny Wong Mr. Wang Xiaofeng

 Founder and Chairman of Medisun Medical Group, years of investment experience in the field of regenerative Medisun, understanding the development and trends of the biotechnology industry

Vice President

Joseph Wang  Dr. Wang Qiyuan

Registered as a doctor, founder of the Hong Kong Stem Cell Center, enriching the clinical experience of regenerative Medisun

Vice President

David Leung Mr. Liang Yaoming

Registered pharmacist, familiar with pharmaceutical regulations and GMP requirements

Vice Chairman

Gregory Cheng Professor Zheng Yanming

Hematology expert, Professor of the University of Macau Health Sciences

Director | Treasurer

Kenneth Lee Dr. Li Zhisheng

Registered as a doctor, B Q Anti-aging Center Consultant

Director

Philip Choy Dr. Cai Shaolong

Ph.D. in Natural Medisun, Madison Biomedical Director

Director

Daniel Tam Dr. Tan Yizhu

Registered as a medical laboratory technologist, director of the Trans-Olympic Blood Bank Laboratory, focusing on cell culture technology for many years

Director

Vivien Leung Ms. Liang Yiqun

 Registered as a medical laboratory technologist, manager of the Trans-Olympic Blood Bank Laboratory, familiar with quality management

Director

Chris Wong Dr. Huang Libao

 Registered as a medical laboratory technologist, director of HKMDPC, molecular biodiagnostic expert

Secretary

Sidney Tam Dr. Tan Guozhen

Chief Executive Officer, Life Clinic, Health Management Consultant

Secretary

Allen Chan Mr. Chen Yuxin

Registered as a medical laboratory technologist, familiar with quality management

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

Hong Kong Regenerative Medisun Association’s recent work plan

Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:

1. Announced the official establishment of the Hong Kong Regenerative Medisun Association

2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals

3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world

4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products

Special thanks

Thank you for taking the time to attend the representatives of the institutions, including:

Medisun Medical Group | Medisun Reproductive Medisun Center

Hong Kong Life Science and Technology Group Co., Ltd.

Standard Pathology Laboratory Co., Ltd.

BIH

Living Tissues company limited

BIB Health Care Centre

Hongxin Medical Center

Austa beauty

Hong Kong International Regenerative Medisun Centre

HKMPDC

Huixin Technology

Guangzhou Biological Institute

Trans-along cord blood bank

Hong Kong Stem Cell Center

Life Length

Biocell

Cordlife

For more information, please visit http://www.medisun.hk/

The famous American vaccine company Profectus settled in Hong Kong

The famous American vaccine company Profectus settled in Hong Kong

First recommend HPV cervical cancer treatment vaccine

BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018

Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, established clinical network and market access capabilities, expected in the second half of 2018 to put into operation.

The company’s first product development program will focus on the development, production and commercial application of prophylactic and therapeutic vaccines for HPV (human papillomavirus)-related lesions and cervical cancer [based on PBSVax® technology developed by Profectus]. ProMed BioSciences also plans to develop and treat hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Chikungunya and Zika, as well as personalized vaccines to treat cancer. The joint venture is expected to launch new vaccines in their respective markets, which will help promote the development of new vaccines, but ultimately the goal is to benefit patients around the world.

Mr. Jeffery Meshulam (first from left), President of Profectus Biotechnology, Mr. Terry Lierman (second from left), Chairman of Medivh Medical Group, and Mr. Danny Wong (fourth from right), founder and executive chairman of Medisun Medical Group, at Profectus ,USA.

– Long-term strategic cooperation to address the huge demand for prevention and treatment of infectious diseases and cancer in Asia

-Profectus’ expertise in vaccine development and platform technology, combined with Medisun’s localized expertise and experience, to establish a leading Hong Kong vaccine company focused on serving Asia

“This strategic cooperation will help establish Profectus’ business in Hong Kong and China. Through close cooperation with Medisun, we can assist Hong Kong and China to develop advanced vaccine technology to help prevent and treat Asian patients. Mr. Jeffrey Meshulam, President of Profectus, said, “We are pleased to be able to work with recognized local partners to achieve the highest standards of scientific research and development integration and medical services.”

“This collaboration will help Profectus and Medisun to jointly produce life-saving vaccines for infectious diseases and cancer, and address the huge medical needs that have not been met in Hong Kong, China and Asia.” Mr. Danny Wong, founder and executive chairman of Medisun Medical Group, said “ProMed BioSciences will leverage Profectus’ expertise in vaccine development and technology, combined with Medisun’s local expertise and close links with healthcare facilities in Hong Kong and China, and government medical regulatory agencies to develop vaccines to provide leadership for Asian patients disease prevention and treatment programs.”

ProMed BioSciences will focus on the following:

• Conduct technical research in Hong Kong or China

• Conduct clinical trials in Hong Kong or China

• Promote the expansion of Medisun Medical Center

• Develop vaccines to address disease prevention needs

• leverage to maximize the expertise of both partners

Mr. Jeffery Meshulam, President of Profectus Biotechnology (first from left), Mr. Terry Lierman, Chairman of Medisun Medical Group (first from right), Mr. Danny Wong, founder and executive chairman of Medisun Medical Group (middle), at the US headquarters of  Profectus.

About ProMed BioSciences

ProMed BioSciences Limited is a joint venture between Profectus BioSciences (USA) and Medisun Medical Group (Hong Kong) in Hong Kong to develop and conduct new vaccine clinical trials and commercial applications to address infectious diseases and cancer in Asia with the huge demand for prevention and treatment.

About Medisun

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative Medisunne products, as well as quality hospitals and treatment centers. Medisun invests extensively in the fields of regenerative and stem cell patent technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, nervous system disease, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun and Harvard University Stem Cell Research Institute, Johns Hopkins Medical School Life Science Center, Tsinghua University and other institutions have long-term cooperation plans to jointly invest in regenerative and stem cell therapy technology, with Medisun as a cooperative business The holding entity and holds global intellectual property rights. Medisun and the University of Maryland’s Institute of Human Virology (IHV) set up a technology clinical trial and development platform for viruses and cancer. Based on the Medisun Biomedical Laboratory in Hong Kong, Radiation will jointly build medical clinics in China and Asia. The experimental resource network promotes the world’s largest clinical research and development platform for virus research and cancer treatment technology. The Medisun Reproductive Centre is located at the Proud Square in Kowloon Bay, Hong Kong. It has a 50,000 square foot stem cell GMP production base, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to develop a rigorous and professional R&D process. Provides immune cell therapy and a variety of stem cell health treatments.

For more information, please visit http://www.medisun.hk/

About Profectus BioSciences

Profectus BioSciences is a clinical stage vaccine development company focused on developing new vaccines for infectious disease and cancer prevention and treatment. The Profectus vaccine is based primarily on the company’s proprietary VesiculoVax™ and DNA vaccine technology platform. By simply using the VesiculoVax™ vaccine alone, B cells can be rapidly expanded to provide protection against emerging infectious diseases that threaten public health and biodefense mechanisms, such as Ebola, Marburg, Chikungunya, Zika virus, equine encephalitis virus, and respiratory syncytial virus. When VesiculoVax™ is used as a vaccine when the immune system is launched with the best pDNA vaccine, the Vesiculo Vax™-directed vaccine expands the triggered T cells into effector cells, which are ideal for attacking virus-infected cells and cancer. Current projects using the Prime / Boost Vaccine System (PBS Vax™) strategy include hepatitis B virus (HBV), human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus ( HIV). Partners and collaborators include UTMB’s Galveston National Laboratory, Yale University, University of Maryland Human Virology Institute, HIV/AIDS Vaccine Immunology Center, National Cancer Institute, National Institutes of Health AIDS Division, Bill And the Melinda Gates Foundation, the International AIDS Vaccine Initiative, the AIDS Vaccine Trial Network and the AIDS Clinical Trial Group. Profectus is funded by Cross Atlantic Capital Partners (“XACP”) in Radnor, Pennsylvania. The main investor in XACP is the Pennsylvania Public School Employees Retirement System (“PSERS”). For more information, please visit www.profectusbiosciences.com

desarrollo de apps con Yabadabadu.mobi

Huelga decir que todos los propietarios de productos de software quieren crear y lanzar una aplicacin de xito, no la que se pierde en un mar de competencia donde todos luchan por ser el mejor. Aqu hay 11 caractersticas imprescindibles y caractersticas de una aplicacin mvil exitosa, que generalmente no dependen de las caractersticas especficas de los dominios comerciales. La mayora de estas cualidades son aplicables a todas las aplicaciones buenas, y pueden ser fcilmente facilitadas por el equipo dedicado que las crea.

Qu es una buena aplicacin?

La respuesta es bastante simple: es la que satisface completamente las necesidades del usuario final, y lo hace de manera rpida y efectiva, con bastante frecuencia en cuestin de varios toques. Podra hacer una sola cosa, pero hacerlo excepcionalmente bien. Dicho esto, qu hace que una aplicacin sea buena, o incluso la mejor en su nicho? Bueno, adems de un nombre pegadizo e identidad visual. Veamos…

Simplicidad para el usuario final
En otras palabras, significa el desarrollo de una interfaz de usuario conveniente y una navegacin simple, basada en las pautas de diseo para la plataforma seleccionada. Tenga en cuenta la calidad principal de cualquier aplicacin mvil que se encuentre entre las mejores. Si su aplicacin incluye la simplicidad, los usuarios no tendrn ninguna razn para buscar una aplicacin similar. Cualquiera que sea la funcionalidad, cuanto ms fcil se entregue, mejor, y no perder usuarios. Esa es una de las cualidades esenciales que ayudan a las aplicaciones mviles populares a reunir y mantener un pblico fiel. Solo asegrate de elegir un equipo que sepa cmo disear bien una aplicacin.

Tanto iOS como Android deberan estar cubiertos
Estas son dos plataformas esenciales para abarcar. Vale la pena sealar que los marcos modernos de desarrollo de aplicaciones multiplataforma, que incluyen PhoneGap, ReactNative y NativeScript, se han convertido en la solucin de ahorro de costos para la prueba de concepto. El desarrollo multiplataforma ahorra los presupuestos iniciales, permite la entrada temprana en el mercado con un MVP y logra de manera efectiva la siguiente tercera caracterstica …

Alto rendimiento
Su aplicacin mvil debe iniciarse rpidamente por primera vez y nunca debe esperar a los usuarios desde ese momento. Tenga en cuenta que su aplicacin debe optimizarse continuamente, y el alto rendimiento se verificar mediante la garanta de calidad.

Seguridad
Esta caracterstica es vital para el desarrollo de aplicaciones especializadas en industrias tales como la atencin mdica y la administracin de dispositivos mviles, donde la confidencialidad de los datos est protegida en el nivel legal. La provisin de seguridad de datos es una de las tendencias de IoT ms discutidas. Es uno de los requisitos principales discutidos con su equipo.

Trabajo fuera de lnea
Naturalmente, hay muchas aplicaciones que dependen principalmente de la disponibilidad de la conexin an Internet. Sin embargo, el acceso a las funciones y el contenido en modo fuera de lnea es imprescindible incluso en sistemas corporativos complejos. Las caractersticas exactas pueden ser tan especficas que sera difcil categorizarlas.

Actualizaciones regulares
Para obtener una popularidad duradera, necesita un ciclo continuo de desarrollo de productos de software: actualizaciones peridicas y evolucin. Tener un equipo para mantener el servidor. Asegrese de que su contenido est hecho de informacin actualizada y relevante. Actualiza la aplicacin con correcciones y nuevas funciones. Desarrolle su producto, hacindolo ms valioso para sus usuarios.

Comentarios y medios de contacto
Est abierto a todos los usuarios. Crear medios de comunicacin mutua para sugerencias, calificaciones y reseas. Incluya medios de contacto y haga clic para llamar, si es necesario. Haga que todo sea lo ms rpido y simple posible, con un nmero mnimo de toques y un mnimo de ingreso de texto.

Opciones de personalizacin
selo donde sea posible. La personalizacin es innegablemente amada por todos. Las configuraciones, fuentes, colores y tamaos flexibles son un ganador, cuando simplemente se trata de elegir una aplicacin entre otras similares. Deje que sus usuarios vean la aplicacin y funcionen de la manera que deseen. Las emociones positivas pueden inclinar la balanza fcilmente a su favor.

Bsqueda
Crea un sistema intuitivo de bsqueda y filtros especficos. La bsqueda es importante cuando la aplicacin entrega contenido complejo. Sin embargo, no olvides hacer que todas las pginas y todos los servicios sean fcilmente accesibles.

Analtica
Esencial como el aire, esta caracterstica permite rastrear a los usuarios y obtener la informacin completa sobre su comportamiento. As es como puedes medir el xito de tu aplicacin. Puede ver dnde puede mejorarlo durante el desarrollo posterior.

Las aplicaciones se distribuyen a travs de la App Store y de Google Play. Envamos tu APP a las tiendas y optimizamos su SEO personalizando la ficha. Despus, todo lo que tienes que hacer es disfrutar de los beneficios de la distribucin en las tiendas: visibilidad gracias al SEO y garanta de calidad por los comentarios y revisiones de los usuarios.

A menos que hayas renunciado voluntariamente a toda la tecnologa moderna, lo ms probable es que sepas que las Apps se han convertido en un gran tema. De hecho, es incluso difcil imaginar realizar algunas de las tareas diarias sin ellas. Con eso dicho, si tienes una aplicacin en pleno funcionamiento o incluso slo en las etapas iniciales de desarrollo o de planificacin, podras estar en el camino de sacar provecho de los posibles grandes beneficios que la cultura de las aplicaciones ha creado.

Contactar:

# https://yabadabadu.mobi/
# Facebook https://www.facebook.com/yabadabaduinternet
# Twitter https://twitter.com/YabadabaduEs
# Google Plus https://plus.google.com/+YabadabaduEsInternet
# Linkedin https://www.linkedin.com/company/yabadabadu/
# YouTube https://www.youtube.com/user/yabadabaduinternet/

C/ Velzquez, 53 2 Izda. Madrid, Spain
Call +34 911 31 06 33

Medisun Regenerative Medical Center and Health Summit

Medisun Regenerative Medical Center and Health Summit

Cancer Vaccine | White House Cancer Lunar Plan | Cancer Proton Beam Treatment

ShenZhen- Hong Kong-GuangZhou

The Medisun Medical Health Summit, co-sponsored by Medisun Regenerative Medical Group, New Life Group and Sunshine Medical Group, was held in Shenzhen, Hong Kong and Guangzhou from September 6 to 9, 2017. The theme of this summit is centered around the prevention and treatment of cancer. The authoritative release of cancer vaccine is the strongest focus of this summit.  

Medisun Medical Group has invited a number of authoritative scientists, medical experts, industry leaders, government agency representatives, business leaders and socialites from the United States, Europe, Japan, Hong Kong and Mainland China to collaborate on cancer prevention worldwide. Leading medical health consultations such as therapeutic technologies, industry regulatory development, and medical platform construction have been fully explored. Nearly 5,000 entrepreneur representatives, medical experts and doctors from the Chinese health industry participated in the listening and sharing.

Dozens of media interviews and reports at the summit

Madison Cancer Vaccine Launch Ceremony

Chairman Danny Wong said: “The advent of cancer vaccine is the strongest gospel of cancer prevention!”

According to the World Health Organization (WHO), approximately 14 million new cancer cases are diagnosed each year worldwide, and this number is expected to reach 21 million by 2030. As global treatment costs rise, cancer prevention measures are becoming more and more important, which has also made cancer prevention and treatment a high-profile international issue. Medisun’s comprehensive introduction of cancer vaccines is undoubtedly the strongest gospel for cancer prevention. The WT1 gene is a gene representing tumorigenesis in humans, and all human cancers are associated with this genetic mutation. The Nobel Institute of Ecological Medical Sciences has discovered a pathway to inhibit mutations in the WT1 gene, which can be vaccinated to produce memory T cells that inhibit WT1 gene mutations, which are immune to humans.

In addition, Medisun is also committed to the development and clinical use of a variety of other vaccines. Most of the vaccine technology comes from the United States, investing in rapid response to the pandemic virus and cancer control vaccine technology platform, with a market size of more than 2 billion US dollars. The vaccines invested by Medisun can be modularized in Asia and China to produce vaccines that are fully compliant with the United States. Including: Zika virus, Chikungunya fever, Zika/Chikununya heat combination, Ebola virus, human papillomavirus HPV treatment vaccine, head and neck cancer, cervical cancer, cervical lesions, simple Herpesvirus HSV, hepatitis C virus HCV, hepatitis B virus HBV,etc.

Mr. Danny Wong, Chairman of Medici Medical Group, was interviewed by the media about the release of cancer vaccine.

Chairman Danny Wong specifically said: “China’s rapid economic development over the past 20 years has been accompanied by a wave of globalization. China has integrated into the international community in various fields. At the same time, China has introduced high-standard medical technologies and services from Europe, the United States and Japan. It is our mission to make full use of Hong Kong’s advantages as a mature international metropolis and special geographical factors to provide the world’s most advanced medical care to the people of the motherland.

On-site participants actively asked questions from the cancer vaccine and new cancer treatment technologies to participate in the seminar.

Medisun participates in the White House Cancer Month Plan

Mr. Terry Lierman said: “The greatest progress and breakthrough of mankind is the birth of cancer vaccine!”

Mr. Terry Lierman, a core member of the White House Cancer Month Program, the NIH of the National Institutes of Health, and the founder of the FDA Board of Directors and director of the Meditech Group, said that cancer landing is an amazing cause. It is planned to complete the treatment of 20,000 cancer patients with 60 different technologies worldwide by 2020. This is a task that would have taken at least 10 years to achieve, and we will now achieve it in 5 years. The cancer “moon landing plan” advocated by former US President Barack Obama in 2016 is also the focus of this summit. The plan is led by former Vice President Joe Biden. The goal is to break the boundaries that hinder the cooperation of researchers and accelerate the research of cancer diagnosis and treatment in the future. 5 years to double the progress of anti-cancer research. The six major US cancer “moon landing programs” include cancer vaccines, high-sensitivity cancer early detection, immunotherapy and combination therapy, single-cell genomic analysis of cancer cells and tumor microenvironment cells, new treatments for childhood cancer, and enhanced data. shared. To this end, the United States and Canada, Hong Kong, Germany, Switzerland, Japan, South Korea and other countries, the first-class research units to establish cooperative relations, large-scale joint cancer research and treatment, toward precision Medisun. The Medisun Medical Group is a member of the Cancer Month Program and will also participate in this historic mission.

Mr. Terry Lierman talks about McGrady’s participation in the White House Cancer Month Plan

Medisun introduces Mayo proton beam therapy

Dr. Michael Haddock said: “The Mayo proton beam is a great advancement in the precise treatment of cancer!”

As the Asian Medical Service Center of the Mayo Clinic in the United States, Medisun invited Dr. Michael Haddock, Chairman of the Mayo Radiation Oncology Clinical Practice Committee and Vice Chairman of the American Society of Surgery Oncology (ACOSOG) Committee to talk about radiotherapy for cancer. Dr. Haddock talked about the current Proton Bean, the world’s leading cancer radiotherapy technology, Mayo currently has the most authoritative equipment, operations and medical team for global proton beam therapy. Mayo’s proton beam therapy program is the exclusive feature of pen beam scanning. It can accurately target tumors and prevent healthy tissues from being affected, thus achieving ideal cancer treatment, especially for treating children with cancer. For cancers with high mortality and lung cancer, proton beam therapy has obvious advantages compared with traditional radiotherapy.

At the Hong Kong Summit, Dr. Michael Haddock (left), the authoritative doctor of Mayo cancer proton beam therapy, answered questions from guests at the scene.

Dr. Michael Haddock (left) and Mr. Terry Lierman (right), the authoritative doctors of Mayo cancer proton beam therapy, at the Guangzhou Summit.

Japanese NKT immune cell therapy

Dr. Degang said: “Cancer vaccine and NKT immune cell therapy are the strongest partner in cancer prevention and treatment!”

Haruhiro Tokuoka, CEO of Riken Immunization and Reproductive Medisun, Japan, Dr. Degang Governing, talked about immunotherapy for cancer. Japan has always been a pioneer in cancer immunotherapy and has extensive clinical experience. Japan Riken and Medisun have worked closely together and established the Medisun Precision Medical Joint Venture, which applies NKT immunocytotherapy outside the traditional cancer treatment to clinical treatment of various types of cancer in the early, middle and late stages, and has clinically proven to greatly improve cancer patients. High quality of immunotherapy at the same time as quality of life with almost no side effects.

Dr. Kazuoka Kazuo of Japan at the Hong Kong Summit to explain the effectiveness of NKT immune cell therapy in clinical treatment of cancer.  

Dean He Jianxing (second from right) of Guangzhou Medical First Hospital visited the Guangzhou Summit and participated in Dr. Degang Zhiwei (third from left) on cell immunotherapy

Precision Medisun and anti-cancer cancer

Ms. Yanglan said: “As a mother, I chose to give my daughter a HPV cervical cancer vaccine; now the launch of the cancer vaccine is even more exciting!”

In today’s society, everyone is tired of work, and it is often the easiest to ignore their good habits, which leads to the emergence of various diseases . In fact, “health is the first wealth of life”, Emerson’s famous interpretation perfectly interpreted the importance of a healthy life to people. Ms. Yang Lan, a well-known Chinese media person, attended the summit as a guest and shared ideas about health and happiness with the guests. She said that the pain caused by cancer patients to the family cannot be expressed in words, and health is good for every family. Precious, we need to follow the development of science and technology to update our medical knowledge. Nowadays, precision Medisun has brought us new choices. While we are not blindly following, we should fully understand the physical condition of ourselves and our families, and choose the right medical health program for ourselves.

Ms. Yang Yu shared about cancer treatment.  

Ms. Wu Shuqing, the Honorary Director of the World Trade Center Association and the Standing Committee of the National Committee of the Chinese People’s Political Consultative Conference, was unable to visit the summit due to the temporary overseas meeting. She also sent a congratulatory message to the summit and congratulated Chairman Danny Wong of the Medisun Medical Group: “The summit has deepened Hong Kong with the Chinese mainland again, we are highly concerned about the medical and health industry. Therefore, I believe that Medisun Medical Group will continue its leading position in the field of medical and health care. Since the beginning, I have seen the entire team of Medisun under the leadership of Chairman Danny Wong. Unremitting efforts and dedication, I am convinced that today’s event is only the beginning, I hope that more results will be shared with the whole society.”

As a pioneer in the field of stem cells, cancer prevention and treatment in the world of regenerative , Medisun Medical Group has been committed to introducing the world’s leading cancer prevention and treatment technologies and providing the most advanced, professional and excellent medical and health services to the society. The release of the cancer vaccine is a revolutionary advancement in the field of cancer prevention. Ancient smallpox is terminally ill, and now a single shot of smallpox disappears; in the past, hepatitis B was terminally ill, and now a vaccine is immunized for life; yesterday, cancer is terminally ill, and today’s cancer vaccine keeps cancer away. Time is advancing and science is progressing. We must have a mentality of accepting progress. We believe that cancer prevention can provide shelter for the family and the health and well-being of  society.

Stay tuned: Hong Kong’s latest publication “CAPITAL” magazine in September, cover story “Mr. Danny Wong, Chairman of Medisun Medical Group” and cover story “New Revolution in Medical Industry”.

You can contact the Hong Kong Medisun Regenerative Medical Center to receive a magazine. Contact as below:

Phone: +(852) 2582 0188

Email: info@medisun.hk

WeChat: medisuninfo

Website: www.medisun.hk

****************************************

Medisun Medical Group

Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative  products, as well as top hospitals and treatment centers. Located on the 25th floor of Ao Teng Plaza, Kowloon Bay, Hong Kong, the Medisun Reproductive Centre has a 50,000-square-foot stem cell GMP production facility, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to be rigorous and professional. The development process provides immune cell therapy and a variety of stem cell health treatments. As the Asian service organization of Mayo Clinic, the center provides Mayo remote consultation and secondary treatment to enable Chinese patients to enjoy authoritative medical services without leaving the country. More than 3,000 biomedical tests provide the most predictable health protection for the health of our clients. Medisun has been fully supporting the development of the new life and health platform, and is committed to the deepening of the new products and technologies of regenerative Medisun through this platform, truly benefiting the health of the whole society.

For more details, please visit http://www.medisun.hk/